U.S. Auto Stock News

NYSE:CC
NYSE:CCChemicals

Is Chemours (CC) Pricing Reflect Recent Volatility And Discounted Cash Flow Outlook

If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the numbers say about value. Chemours' share price closed at US$18.02, with returns of 14.1% over the last 30 days, 47.1% year to date and 16.9% over the past year, while the 7-day return of a 14.8% decline and longer term 3-year and 5-year returns of 42.4% and a 16.4% decline show a mixed picture for...
NYSE:GDDY
NYSE:GDDYIT

GoDaddy (GDDY) Margin Compression Tests Bullish EPS Growth Narrative

GoDaddy (GDDY) just posted its FY 2025 numbers with Q4 revenue of US$1.27 billion and basic EPS of US$1.82, while trailing 12 month revenue came in at US$5.0 billion and EPS at US$6.34. Over the past six quarters, revenue has moved from US$1.15 billion in Q3 2024 to US$1.27 billion in Q4 2025, with quarterly EPS ranging from US$1.36 in Q3 2024 to US$1.82 in the latest quarter. Investors may now focus on how these top line and EPS trends line up with expected earnings growth. With net margins...
NYSE:CVS
NYSE:CVSHealthcare

Does Medicare Advantage Reimbursement Uncertainty Reshape The Bull Case For CVS Health’s Platform Strategy (CVS)?

Earlier in February, CVS Health faced investor concerns after federal Medicare officials proposed minimal payment updates and risk‑adjustment changes for 2027 Medicare Advantage plans, raising questions about reimbursement levels for its Aetna insurance unit. At the same time, heightened put option activity and ongoing integration of Oak Street Health, alongside legal settlements and new sports health partnerships, underscored how policy risk, primary care expansion, and brand-building...
NYSE:VIK
NYSE:VIKHospitality

A Look At Viking Holdings (VIK) Valuation After New US River Itineraries And PGA TOUR Partnership

Viking Holdings (VIK) has opened bookings for a new set of 2027 Mississippi and Ohio river itineraries, expanding its U.S. river cruise offerings shortly after securing a multi year marketing partnership with the PGA TOUR. See our latest analysis for Viking Holdings. The new river itineraries and the recent PGA TOUR marketing tie up come as Viking Holdings trades at US$79.18, with a 30 day share price return of 13.62% and a 1 year total shareholder return of 61.23%, suggesting momentum has...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Akamai And NVIDIA Push Zero Trust Security Deeper Into Critical Infrastructure

Akamai Technologies (NasdaqGS:AKAM) and NVIDIA have launched an agentless security solution for operational technology and industrial control systems. The offering uses a hardware based Zero Trust model aimed at protecting critical infrastructure without touching fragile or legacy software stacks. The collaboration targets sectors such as energy and transportation where regulatory expectations and cyber threats to industrial equipment are rising. Akamai is best known for content delivery,...
NYSE:MHK
NYSE:MHKConsumer Durables

Is Mohawk Industries (MHK) Offering Opportunity After Recent Share Price Weakness?

If you are wondering whether Mohawk Industries at around US$123.48 is offering fair value or a potential discount, you are not alone. The answer depends on which valuation lens you use. The share price has moved around recently, with a 5.7% decline over the last 7 days, a 2.5% gain over 30 days, a 12.8% return year to date, and 4.1%, 22.0% and 32.4% decline over the last 1, 3 and 5 years respectively. These movements can change how investors think about both opportunity and risk. Recent...
NYSE:EVH
NYSE:EVHHealthcare Services

Evolent Health Q4 Loss Of US$3.84 Per Share Tests Bullish Margin Turnaround Narrative

Evolent Health FY 2025 earnings snapshot Evolent Health (EVH) closed FY 2025 with fourth quarter revenue of US$468.7 million and a basic EPS loss of US$3.84, as the company continued to report negative net income. Over recent periods, revenue has ranged from US$444.3 million to US$483.6 million per quarter, while quarterly basic EPS has stayed in loss-making territory between US$0.24 and US$3.84. This gives investors a clear view of the trade off between top line scale and ongoing earnings...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

How Investors Are Reacting To Fortinet (FTNT) Margin Concerns After a Strong Earnings Beat

Fortinet recently delivered fourth-quarter 2025 results that surpassed its own guidance and market expectations, yet Freedom Capital Markets downgraded the company citing margin risks from rising memory costs, foreign exchange volatility, and heightened competition. While Fortinet’s services segment benefited from growth in Unified SASE cloud solutions and recent acquisitions, the downgrade highlights investor concern that customer caution on contract duration and cost pressures could...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI (TEM) Loss Deepens To US$0.30 EPS As Premium Valuation Thesis Faces Test

Tempus AI (TEM) just posted its FY 2025 numbers with Q4 revenue of US$367.2 million, a basic EPS loss of US$0.30, and net income loss of US$54.2 million, setting the tone for how investors will read the rest of the year. The company reported revenue of US$200.7 million in Q4 2024 and US$367.2 million in Q4 2025, while quarterly basic EPS moved from a loss of US$0.07 to a loss of US$0.30 over the same period, so the key question now is how to weigh that top line against the still negative...
NYSE:BROS
NYSE:BROSHospitality

Assessing Dutch Bros (BROS) Valuation After Strong Q4 Results And 2026 Growth Guidance

Dutch Bros (BROS) has given investors a fresh data point to assess, pairing a stronger than expected fourth quarter and full year 2025 performance with higher 2026 revenue guidance and visible progress on new formats and markets. See our latest analysis for Dutch Bros. Despite the stronger recent earnings and higher 2026 revenue guidance, Dutch Bros’ share price return has been under pressure, with a 30 day share price return of a 13.64% decline and a year to date share price return of an...
NasdaqGS:FCNC.A
NasdaqGS:FCNC.ABanks

Margin Compression At First Citizens BancShares (FCNCA) Challenges Bullish Earnings Narrative

First Citizens BancShares (FCNCA) has wrapped up FY 2025 with Q4 total revenue of US$2.4b and basic EPS of US$45.78, alongside net income of US$566m that feeds into a trailing 12 month net profit margin of 23.8%, compared with 29.1% a year earlier. Over recent periods, the bank has seen total revenue move between US$2.1b and US$2.4b per quarter and quarterly EPS range from US$34.47 to US$49.18. This gives investors a clear set of numbers to weigh against a five year earnings growth rate of...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

NANO Nuclear Energy (NNE) Valuation After New Gulf KRONOS MMR Partnership With EHC Investment

NANO Nuclear Energy (NNE) just signed a Memorandum of Understanding with Abu Dhabi based EHC Investment L.L.C. to explore a joint venture focused on its KRONOS micro modular reactor and related nuclear supply chains in the Gulf region. See our latest analysis for NANO Nuclear Energy. The MOU announcement comes after a mixed run for the stock, with a 7% 1 day share price return and 8.5% 7 day share price return contrasting with a 17.05% 30 day share price decline and 8.23% 1 year total...
NasdaqCM:TYGO
NasdaqCM:TYGOElectrical

Tigo Energy (TYGO) Swings To Q4 Profit Challenging Longstanding Loss-Making Narrative

Tigo Energy (NasdaqCM:TYGO) closed out FY 2025 with Q4 revenue of US$30.0 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$103.5 million and a basic EPS loss of US$0.03. The company has seen quarterly revenue move from US$14.2 million in Q3 2024 to US$30.0 million in Q4 2025, while basic EPS shifted from a loss of US$0.22 to a profit of US$0.17 over the same span, setting up a results season in which investors will be weighing improving earnings against a still...
NasdaqCM:INVZ
NasdaqCM:INVZElectronic

Innoviz Technologies (INVZ) Revenue Growth Versus Persistent Losses Tests Bullish Narratives

Innoviz Technologies (INVZ) just posted its FY 2025 numbers, with Q4 revenue at US$12.7 million and a basic EPS loss of US$0.10, alongside a trailing twelve month revenue base of US$55.1 million and a full year EPS loss of US$0.34. Over the past two reported years, the company has seen quarterly revenue range from US$4.5 million to US$17.4 million and basic EPS losses between US$0.07 and US$0.15. This gives investors a clearer view of how the top line and per share results have been tracking...
NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

Is It Too Late To Consider IDEXX Laboratories (IDXX) After Strong Multi‑Year Share Price Gains?

Wondering if IDEXX Laboratories at around US$657 a share still makes sense for your portfolio, or if the price is getting ahead of itself? The stock has seen mixed moves recently, with a 3.5% gain over the last 7 days, a 5.8% decline over the past month, and returns of 43.6% over 1 year and 40.1% over 3 years. Investors have been reacting to ongoing updates around the animal diagnostics and pet care market, including continued attention on long term demand for veterinary services and...
NYSE:CPRI
NYSE:CPRILuxury

Capri Holdings Puts Finance And Operations Under Tyler Reddien For Turnaround

Capri Holdings (NYSE:CPRI) has appointed Tyler Reddien as its new Chief Financial Officer and Chief Operating Officer. Reddien steps into the dual role as the company pursues its plans in the global luxury fashion market. Capri Holdings, the owner of luxury brands in the global fashion and accessories space, now has a single executive overseeing both its finance and operations functions. For investors, a combined CFO and COO role can concentrate responsibility for capital allocation, cost...
NYSE:KBR
NYSE:KBRProfessional Services

Did Winning Iraq’s Majnoon Oil Field Services Deal Just Shift KBR’s (KBR) Investment Narrative?

KBR recently announced it had been awarded a major Integrated Field Management Services contract by Basra Oil Company for Iraq’s Majnoon Oil Field, one of the world’s largest oil assets with estimated reserves above 38.00 billion barrels, covering upstream engineering, operations, maintenance, and AI-enabled digital optimization. The contract deepens KBR’s role in Iraq’s energy sector while combining local employment and skills transfer with advanced digital engineering to modernize a...
NYSE:EHC
NYSE:EHCHealthcare

A Look At Encompass Health (EHC) Valuation After New Hospital Plan And Dividend Declaration

Dividend and expansion news in focus Encompass Health (EHC) has caught investor attention after its board declared a quarterly cash dividend of $0.19 per share, alongside plans for a new 50-bed inpatient rehabilitation hospital in Flowood, Mississippi. See our latest analysis for Encompass Health. At a share price of $106.13, Encompass Health has recently seen a 9.25% 1 month share price return, while its 1 year total shareholder return of 7.65% and 3 year total shareholder return of about 9x...
NYSE:STWD
NYSE:STWDMortgage REITs

Starwood Property Trust Margin Reliant On US$247 Million One Off Gain Challenges Bullish Narratives

Starwood Property Trust (STWD) just wrapped up FY 2025 with fourth quarter revenue of US$148.8 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$547.9 million and EPS of US$1.15 that reflects reported earnings growth of 16.7% over the past year. Over recent quarters, revenue has ranged from US$125.7 million to US$148.8 million with basic EPS between US$0.19 and US$0.38, while trailing twelve month revenue has moved between US$359.6 million and US$547.9 million as...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies (SPXC) Margin Expansion Reinforces Bullish Earnings Narratives Despite Premium P/E

SPX Technologies (SPXC) has wrapped up FY 2025 with fourth quarter revenue of US$637.3 million and basic EPS of US$1.57, while trailing twelve month revenue came in at about US$2.3 billion alongside EPS of US$5.13. Over the past few quarters the company has seen revenue move from US$533.7 million in Q4 2024 to US$637.3 million in Q4 2025, with basic EPS stepping from US$1.22 to US$1.57 over the same period. Those results sit on top of trailing earnings growth of 21.7% and a net margin of...
NYSE:JPM
NYSE:JPMBanks

A Look At JPMorgan Chase’s Valuation As Jamie Dimon Flags Rising Market And Credit Risks

JPMorgan Chase (JPM) has moved back into the spotlight after CEO Jamie Dimon compared today’s market conditions with the run up to the 2008 financial crisis and highlighted growing risks related to lending and elevated asset prices. See our latest analysis for JPMorgan Chase. Jamie Dimon’s warnings are landing at a time when sentiment around big banks is already fragile, with JPMorgan’s recent Q4 earnings miss, a 1 day share price return of 2.02% and a year to date share price decline of...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Is It Too Late To Consider MYR Group (MYRG) After Its 1 Year 118% Surge?

If you are wondering whether MYR Group is still good value after its strong run, the key question now is how its current share price compares with what the business might reasonably be worth. The stock last closed at US$274.01, with reported returns of 5.0% over the past week, 9.3% over the past month, 20.9% year to date, 117.7% over 1 year, 125.2% over 3 years and 340.4% over 5 years. This naturally raises questions about how much optimism is already reflected in the price. Recent coverage...
NYSE:LOW
NYSE:LOWSpecialty Retail

Lowe’s (LOW) Margin Slippage In Q4 Tests Bullish Pro Growth Narrative

Lowe’s Companies (LOW) has just wrapped up FY 2026 with fourth quarter revenue of US$20.6b and basic EPS of US$1.78 on net income of US$999m, setting the tone for how the home improvement chain is exiting the year. Over the past two reported fourth quarters, revenue has moved from US$18.6b in FY 2025 to US$20.6b in FY 2026, while quarterly basic EPS shifted from US$2.00 to US$1.78. This gives investors a clear snapshot of how top line scale and per share earnings are lining up. With trailing...
NYSEAM:NHC
NYSEAM:NHCHealthcare

Is It Too Late To Consider National HealthCare (NHC) After A 77% One-Year Surge?

Wondering if National HealthCare at around US$160 a share still offers value or if the easy gains are behind it? This article focuses squarely on what the current price might mean for you as an investor. The stock closed at US$160.33, with a 1.1% decline over the last 7 days, a 10.0% return over 30 days, 22.9% year to date, 77.1% over 1 year and 213.6% over 3 years. These moves naturally raise questions about how much future upside or downside the market is now pricing in. Recent coverage...